Listed

Processa Pharmaceuticals, Inc.: Form 10-Q/A for the period ended Jun 30, 2013

Filed with the SEC on Sep 6, 2013 and accepted by EDGAR at Sep 6, 2013, 16:14 ET.

Share

Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-04-01 to 2013-06-30$97.3kus-gaap:Revenues
Revenue6 months2013-01-01 to 2013-06-30$116.5kus-gaap:Revenues
Cost of revenue3 months2013-04-01 to 2013-06-30$61.5kus-gaap:CostOfGoodsSold
Cost of revenue6 months2013-01-01 to 2013-06-30$73.7kus-gaap:CostOfGoodsSold
Gross profit3 months2013-04-01 to 2013-06-30$35.8kus-gaap:GrossProfit
Gross profit6 months2013-01-01 to 2013-06-30$42.8kus-gaap:GrossProfit
Research and development3 months2013-04-01 to 2013-06-30$63.4kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2013-01-01 to 2013-06-30$135.0kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2013-04-01 to 2013-06-30$665.6kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2013-01-01 to 2013-06-30$1.4mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2013-04-01 to 2013-06-30−$33.8kus-gaap:InterestExpense
Interest expense6 months2013-01-01 to 2013-06-30−$49.6kus-gaap:InterestExpense
Net income3 months2013-04-01 to 2013-06-30−$726.6kus-gaap:NetIncomeLoss
Net income6 months2013-01-01 to 2013-06-30−$1.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2013-04-01 to 2013-06-30−$0.34us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2013-01-01 to 2013-06-30−$0.79us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2013-01-01 to 2013-06-30−$1.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2013-01-01 to 2013-06-30$7.3kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-06-30$629.8kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-06-30$937.8kus-gaap:AssetsCurrent
Total assetsAt period end2013-06-30$3.5mus-gaap:Assets
Current liabilitiesAt period end2013-06-30$2.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-06-30$2.5mus-gaap:Liabilities
Shareholders' equityAt period end2013-06-30$1.0mus-gaap:StockholdersEquity
Shares outstandingAt period end2013-06-307,029,397 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001393905-13-000498. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.